Ciclopirox and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is reported as a side effect among people who take Ciclopirox (ciclopirox), especially for people who are female, 60+ old, also take Levofloxacin, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Thrombocytopenia when taking Ciclopirox. It is created by eHealthMe based on reports of 2,627 people who have side effects when taking Ciclopirox from the FDA, and is updated regularly.

What is Ciclopirox?

Ciclopirox has active ingredients of ciclopirox. eHealthMe is studying from 2,646 Ciclopirox users. Check the latest studies of Ciclopirox.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,791 drugs and 4,871 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On Jul, 15, 2026

2,627 people reported to have side effects when taking Ciclopirox.
Among them, 20 people (0.76%) have Thrombocytopenia.

Could Ciclopirox cause Thrombocytopenia?

Among these 20 people:

What is the gender of people who have Thrombocytopenia when taking Ciclopirox? *

female: 60 %
male: 40 %

What is the age of people who have Thrombocytopenia when taking Ciclopirox? *

What are other drugs people take besides Ciclopirox? *

What are other side effects people have besides Thrombocytopenia? *

Anaemia (lack of blood): 8 people, 40.00%
Acute Kidney Failure: 6 people, 30.00%
Cellulitis (infection under the skin): 5 people, 25.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 5 people, 25.00%
Hypokalemia (low potassium): 5 people, 25.00%
Unilateral Hydronephrosis (kidney stone that causes obstruction of the ureter): 5 people, 25.00%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 5 people, 25.00%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 5 people, 25.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 25.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 25.00%

What are the existing conditions these people have? *

Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 25.00%
Platelet Aggregation Inhibition: 5 people, 25.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 25.00%
Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 20.00%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 15.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 1 person, 5.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ciclopirox and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ciclopirox:

Ciclopirox (2,646 reports)

Thrombocytopenia treatments and more:

Thrombocytopenia (285,083 reports)

Browse all side effects of Ciclopirox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,791 drugs)

Browse all the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,871 conditions)

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox (the active ingredients of Ciclopirox) and Ciclopirox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.